Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 3/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2816581 | 0.83 | MAPK1 (0.40) | ESR1ESR2TSHRNPC1RAB9A | |
| SCHEMBL8251933 | 0.82 | APP (0.50) | APPTSHRNPC1RAB9AMEN1 | |
| SCHEMBL18911060 | 0.78 | ESR1 (0.39) | APPESR1ESR2IDO1PTPN2 | |
| SCHEMBL133476 | 0.78 | TSHR (0.48) | IDO1TSHR | |
| SCHEMBL18574373 | 0.78 | APP (0.36) | APPESR1ESR2IDO1PTPN2 | |
| SCHEMBL12380890 | 0.78 | TSHR (0.36) | APPESR1TSHRKMT2A | |
| SCHEMBL19144067 | 0.77 | ESR1 (0.42) | ESR1ESR2TSHRMEN1KMT2A | |
| SCHEMBL3434078 | 0.76 | IDO1 (0.59) | IDO1PTPN2PTPN1PTPN6KMT2A | |
| SCHEMBL8750541 | 0.76 | SHBG (0.55) | APPESR1ESR2IDO1PTPN2 | |
| SCHEMBL18473524 | 0.76 | ESR1 (0.37) | APPESR1ESR2IDO1PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230279560-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-09-07 | — | — | US | claimed |
| EP-4189141-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-06-07 | — | — | EP | claimed |
| CN-115943229-A | Cyclic compounds as aromachemicals | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | claimed |
| US-20230279560-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-09-07 | — | — | US | disclosed |
| EP-4189141-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | BASF SE (DE) | 2023-06-07 | — | — | EP | disclosed |
| CN-115943229-A | Cyclic compounds as aromachemicals | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-0275489-B1 | BENZALDEHYDE DERIVATIVES, THEIR PREPARATION AND APPLICATION | BASF Aktiengesellschaft (DE) | 1989-08-09 | — | — | EP | disclosed |
| US-4814510-A | Novel benzaldehyde derivatives, their preparation, and their use | BASF AKTIENGESELLSCHAFT (DE) | 1989-03-21 | — | — | US | disclosed |
| EP-0275489-A1 | Benzaldehyde derivatives, their preparation and application | BASF Aktiengesellschaft (DE) | 1988-07-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230279560-A1 | CYCLIC COMPOUNDS AS AROMA CHEMICALS | C1S, VDAC2, VDAC3 | APP 1039/4885ESR1 353/4885ESR2 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.